| Item 3.02 |
Unregistered Sales of Equity Securities. |
On the Closing Date, simultaneously with the consummation of the IPO, pursuant to the Private Placement Purchase Agreements, the Company
completed the private sale (the “Private Placement”) of an aggregate of 672,000 private placement units (the “Private Placement Units”) to the Sponsor and the Representatives, at a price of $10.00 per Private Placement Unit
generating aggregate gross proceeds of $6,720,000. Of the 672,000 Private Placement Units, (A) the Sponsor purchased 400,000 Private Placement Units for $4,000,000, (B) CCM purchased 176,800 Private Placement Units for $1,768,000 and
(C) Northland purchased 95,200 Private Placement Units for $952,000. The Private Placement Units (including the underlying securities) are identical to the Units, except that, they are (i) subject to certain limited exceptions, subject to
transfer restrictions until 180 days following the consummation of the Company’s initial business combination, (ii) entitled to registration rights and (iii) with respect to the private placement warrants included in the Private
Placement Units held by the Representatives, will not be exercisable more than five years from the commencement of the IPO in accordance with FINRA Rule 5110(g)(8). The issuance of the Private Placement Units was made pursuant to the exemption from
registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. |
On February 19, 2026, in connection with the IPO, Mohammad A.
Kahn, Thomas A. Decker, and Celso L. White (collectively with Mohammad A. Kahn and Thomas A. Decker, the “Directors”) were appointed as independent directors to the Company’s board of directors (the “Board”). Effective
February 19, 2026, each of Mohammad A. Kahn, Thomas A. Decker and Celso L. White were also appointed to the Board’s audit committee and compensation committee, with Mr. Decker serving as the chair of the audit committee and
Mr. White serving as the chair of the compensation committee.
On February 17, 2026, each Director entered into (i) the
Letter Agreement and (ii) an Indemnity Agreement. In addition, the Sponsor assigned and transferred 85,000 Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), to each Director for their
service on the Board, of which 8,500 Class B Ordinary Shares vested on the Closing Date and the remaining 76,500 Class B Ordinary Shares will vest in six quarterly installments through the 18-month
anniversary of the Closing Date, in each case, pursuant to a Securities Assignment Agreement by and among the Company, the Sponsor, and each Director, as may be amended from time to time. All unvested Class B Ordinary Shares will vest
immediately upon an initial business combination, and any unvested shares will be forfeited for no consideration if a Director ceases to serve on the Board.
The Company will reimburse the Directors for reasonable
out-of-pocket expenses incurred in fulfilling their roles as directors, as well as expenses related to identifying potential target businesses and performing due
diligence on suitable business combinations. Except as set forth above or otherwise disclosed in the Registration Statement, no compensation will be paid to the Directors prior to or in connection with the Company’s initial business
combination; provided, however, that the Board may approve the payment of advisory fees to the Directors for board committee service and extraordinary administrative and analytical services.
Other than the foregoing, none of the Directors is party to any arrangement or understanding with any person pursuant to which they were
appointed as directors, nor is any Director party to any transaction required to be disclosed under Item 404(a) of Regulation S-K involving the Company. The foregoing descriptions of the Letter Agreement and
the Indemnity Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Letter Agreement, the form of Indemnity Agreement and the form of Securities Assignment Agreement filed as Exhibits 10.7,
10.8 and 10.9, respectively, to this Current Report on Form 8-K, and are incorporated herein by reference.
| Item 5.03 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On February 17, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the
“Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on February 17, 2026. The terms of the Amended and Restated Memorandum and Articles of Association
are set forth in the Registration Statement and are incorporated herein by reference. The description of the Amended and Restated Memorandum and Articles of Association does not purport to be complete and is qualified in its entirety by reference to
the Amended and Restated Memorandum and Articles of Association, a copy of which is attached as Exhibit 3.1 hereto and incorporated herein by reference.
2